INHIBITION OF CD26/DIPEPTIDYL PEPTIDASE IV ACTIVITY IN VIVO PROLONGS CARDIAC ALLOGRAFT SURVIVAL IN RAT RECIPIENTS1,2
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
1976 • 225,752 citations
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
1976 • 200,127 citations
Proline-Dependent Structural and Biological Properties of Peptides and Proteins
1993 • 548 citations
Direct Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26
1993 • 493 citations
Proline motifs in peptides and their biological processing
1995 • 433 citations
In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple Sclerosis
1985 • 307 citations
Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody.
1984 • 239 citations
Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.
1991 • 208 citations
Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function.
1991 • 169 citations
The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro
1987 • 141 citations
Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV.
1994 • 125 citations
A Novel Form of Dipeptidylpeptidase IV Found in Human Serum.
1995 • 118 citations
Dipeptidyl Peptidase IV in Human T Lymphocytes
1989 • 100 citations
Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells.
1996 • 90 citations
Involvement of dipeptidyl peptidase IV in an in vivo immune response
1992 • 81 citations
Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine.
1988 • 79 citations
Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation
1991 • 61 citations
Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients
1994 • 59 citations
CD4-positive suppressor cells block allotransplant rejection.
1995 • 53 citations
FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activation
1990 • 49 citations
Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjects
1994 • 49 citations
ABROGATION BY RAPAMYCIN OF ACCELERATED REJECTION IN SENSITIZED RATS BY INHIBITION OF ALLOANTIBODY RESPONSES AND SELECTIVE SUPPRESSION OF INTRAGRAFT MONONUCLEAR AND ENDOTHELIAL CELL ACTIVATION, CYTOKINE PRODUCTION, AND CELL ADHESION1,2
1994 • 47 citations
Serum glycylproline p-nitroanilidase activity in rheumatoid arthritis and systemic lupus erythematosus
1978 • 38 citations
Dipeptide-derived diphenyl phosphonate esters: mechanism-based inhibitors of dipeptidyl peptidase IV
1996 • 38 citations
Costimulation of CD4+ and CD8+ T cells through CD26: The ADA-binding epitope is not essential for complete signaling
1995 • 26 citations
Dipeptidyl peptidase IV (DP IV) activity in serum and on lymphocytes of MRL/Mp-lpr/lpr mice correlates with disease onset
1994 • 16 citations
IN VIVO INHIBITION OF DIPEPTIDYL PEPTIDASE IV (DPP IV) BY PRO-PRO-DIPHENYL PHOSPHONATE (DIPROFEN)
1996 • 3 citations